Thursday, March 31, 2011 7:33:41 PM
Mr. Feelgood, I'm neither short nor long in this co. but wanted to ask you a few questions.
I couldn't help but notice that the various message boards around the internet for NNVC are populated by you and a handful of others who seem to have been around since the inception. Not only that, but many of the early investors have also defended/touted Seymour's prior venture of Saliva Diagnostics which traded under a variety of symbols before it finally found itself flushed down into the cesspool where things can get quite brown if you know what I mean.
It's very possible you've disclosed this in the past, but I'm just wondering why the vigor for you to defend Dr. Seymour so much? It seems like he may be a nice guy but he's also the head of a company that has made many unfilled promises in the past. What, exactly, is your own personal genesis with Seymour's ventures, and why defend/promote them to the extent that you do? Is it possible you could give a synopsis of your investment history? Did you just buy in on the open market and got involved that way?
I realize my questions are rude and forward on some level, but hey, it's the wild internet after all.
Any info you can give on your early and enthusiastic promotion of Saliva/Nanoviricides would be appreciated. I realize I'm behind the eight-ball when suddenly popping up to ask such a Q.
Recent NNVC News
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 09/27/2024 08:15:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/09/2024 08:30:39 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 08/09/2024 08:05:25 PM
- NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • InvestorsHub NewsWire • 05/02/2024 02:07:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/16/2024 09:53:32 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/14/2024 09:55:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/19/2024 09:44:48 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 12/04/2023 09:08:49 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 10/13/2023 08:30:41 PM
Lingerie Fighting Championships Signs Broadcast Deal With Maybacks Global Entertainment • BOTY • Sep 26, 2024 9:00 AM
Maybacks Global Entertainment and Lingerie Fighting Championships Enter Into Broadcast And Revenue Sharing Agreement • AHRO • Sep 26, 2024 8:30 AM
North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM
CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM
Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM
Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM